Page 3 - Gala Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gala therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gala Therapeutics Today - Breaking & Trending Today

CT-Based Commercial Software Applications

Features of commercial platforms, including the technologies they are based on, the metrics they can generate, & their clinical correlations & applications. ....

United States , South Korea , Lee Olsen , Johns Hopkins , Ann Biomed Eng , Van Holsbeke , Kizhakke Puliyakote , Glob Health Epidemiol Genom , Fleischner Society , National Institutes Of Health , Boehringer Ingelheim , Education Alliance , University Of Michigan , American Lung Association , Konica Minolta , National Heart , Blood Institute , Parametric Response Mapping , Continuing Education , United Therapeutics , National Institutes , Gala Therapeutics , American Lung , Data Safety Monitoring Boards , Health Epidemiol , Aerosol Med Pulm Drug ,

First Case Using Non-thermal Pulsed Energy for Chronic Bronchitis

Gala Therapeutics, Inc., a developer of medical devices to treat pulmonary disease, today announced the first worldwide commercial procedures using the - Click here if this is your press release! - Travel News | eTurboNews | eTN ....

Lina Zuccatosta , Jonathan Waldstreicher , Michela Bezzi , Stefano Gasparini , University Hospital Brescia , World Association For Bronchology , University Hospital Ancona , Polytechnic University Of Marche , Gala Therapeutics Inc , Gala Therapeutics , Bronchial Rheoplasty , Professor Stefano Gasparini , Polytechnic University , Director Pulmonary Diseases Unit , Interventional Pulmonology , Vice Chair , World Association ,

Gala Therapeutics Announces First Commercial Cases Worldwide with RheOx® System for Chronic Bronchitis

/PRNewswire/ Gala Therapeutics, Inc. (Gala), a developer of medical devices to treat pulmonary disease, today announced the first worldwide commercial. ....

Lina Zuccatosta , Jonathan Waldstreicher , Michela Bezzi , Stefano Gasparini , University Hospital Brescia , World Association For Bronchology , European Union , Drug Administration Breakthrough Device Designation , University Hospital Ancona , Polytechnic University Of Marche , Gala Therapeutics Inc , Gala Therapeutics , Bronchial Rheoplasty , Professor Stefano Gasparini , Polytechnic University , Director Pulmonary Diseases Unit , Interventional Pulmonology , Vice Chair , World Association , Drug Administration Breakthrough Device , San Carlos , Retrieved April ,

Bronchoscopic Interventions Promising for Patients With COPD

Several emerging bronchoscopic treatments have the potential to improve the quality of life for patients with chronic obstructive pulmonary disease. ....

United States , Christian Ghattas , American College Of Chest Physicians , Nuvaira Inc , Ohio State University Medical Center , American College , American Journal , Critical Care , European Respiratory , Respiratory Questionnaire , Leicester Cough Questionnaire , Gala Therapeutics , Chronic Obstructive Pulmonary Disease Copd , Chronic Obstructive Pulmonary Disease , Chronic Obstructive Lung Disease , Chronic Bronchitis , Nt Ears , Severe Chronic Obstructive Pulmonary Disease , Quality Of Life , Ealth Related Quality Of Life , Thoracic Region Of Chest ,

Doug Godshall to Chair Gala Therapeutics Board of Directors

Doug Godshall to Chair Gala Therapeutics Board of Directors
News provided by
Share this article
Share this article
SAN CARLOS, Calif., March 2, 2021 /PRNewswire/ Gala Therapeutics, Inc. (Gala), a developer of medical devices to treat chronic bronchitis and other pulmonary diseases, announced today that it has appointed Douglas Godshall to chair of its Board of Directors. Since 2017, Godshall has been President and CEO of Shockwave Medical, a medical device company developing a proprietary non-invasive treatment for atherosclerotic cardiovascular disease that locally delivers sonic pressure waves to calcified plaque. From 2006 to 2016, Godshall was CEO and a director of HeartWare International, a medical device company created by Apple Tree Partners (ATP). HeartWare was acquired by Medtronic for $1.1 billion in 2016. Before HeartWare, Godshall held various executive leadership roles at Boston Scientific. ....

New York , United States , United Kingdom , City Of , San Carlos , Northeastern University , San Francisco , Doug Godshall , Jonathan Waldstreicher , Douglas Godshall , Seth Harrison , Heartware International , Lafayette College , Boston Scientific , Device Manufacturer Association , Eyepoint Pharmaceuticals , Gala Therapeutics Inc , Gala Therapeutics , Shockwave Medical , Apple Tree Partners , Before Heartware , Medical Device Manufacturer , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் ,